跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,686 条关于
“Alkermes PLC”
全部
3,686
临床试验
808
药物
529
机构
1,747
资讯
602
去年
Federal Circuit Transfers $66 Million Patent Dispute Between Alkermes and Acorda Therapeutics
去年
Alkermes Presents Positive Phase 1b Data for ALKS 2680 in Narcolepsy Type 2 and Idiopathic Hypersomnia
去年
Mural Oncology Cuts 90% of Workforce Following Failed Cancer Immunotherapy Trials
11个月前
Alkermes Acquires Avadel for Up to $2.1B to Accelerate Sleep Medicine Market Entry
6个月前
Alkermes CEO Richard Pops to Retire After 35-Year Leadership, Blair Jackson Named Successor
5个月前
Hypersomnia Pipeline Advances with Novel Therapies from Avadel, Zevra, and Alkermes
3年前
hVIVO PLC Develops hMPV Human Challenge Model
去年
FDA Panel Approves Sage's Novel Antidepressant for Postnatal Depression, Rejects Alkermes' Treatment
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
去年
Alkermes' Alixorexton Shows Promise in Phase 2 Narcolepsy Trial, Achieving Normal Wakefulness Levels
第 1 页,共 61 页
上一页
下一页